EXOR NV (EXO.AS) Fundamental Analysis & Valuation

AMS:EXO • NL0012059018

Current stock price

63.75 EUR
-1.05 (-1.62%)
Last:

This EXO.AS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. EXO.AS Profitability Analysis

1.1 Basic Checks

  • EXO had negative earnings in the past year.
  • EXO had a positive operating cash flow in the past year.
  • Of the past 5 years EXO 4 years were profitable.
  • EXO had a positive operating cash flow in each of the past 5 years.
EXO.AS Yearly Net Income VS EBIT VS OCF VS FCFEXO.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B 15B

1.2 Ratios

  • The Return On Assets of EXO (-1.62%) is worse than 72.41% of its industry peers.
  • EXO has a worse Return On Equity (-1.78%) than 65.52% of its industry peers.
Industry RankSector Rank
ROA -1.62%
ROE -1.78%
ROIC N/A
ROA(3y)14.68%
ROA(5y)9.18%
ROE(3y)25.64%
ROE(5y)17.39%
ROIC(3y)N/A
ROIC(5y)N/A
EXO.AS Yearly ROA, ROE, ROICEXO.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 30

1.3 Margins

  • In the last couple of years the Profit Margin of EXO has grown nicely.
  • EXO's Operating Margin has improved in the last couple of years.
  • With a Gross Margin value of -5096.69%, EXO is not doing good in the industry: 63.79% of the companies in the same industry are doing better.
  • EXO's Gross Margin has improved in the last couple of years.
  • The Profit Margin and Operating Margin are not available for EXO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM -5096.69%
OM growth 3Y119.43%
OM growth 5Y70.93%
PM growth 3Y165.23%
PM growth 5Y113.99%
GM growth 3Y61.62%
GM growth 5Y43.9%
EXO.AS Yearly Profit, Operating, Gross MarginsEXO.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60 80 100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. EXO.AS Health Analysis

2.1 Basic Checks

  • EXO does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • EXO has less shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, EXO has less shares outstanding
  • The debt/assets ratio for EXO is higher compared to a year ago.
EXO.AS Yearly Shares OutstandingEXO.AS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
EXO.AS Yearly Total Debt VS Total AssetsEXO.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50B 100B 150B

2.2 Solvency

  • An Altman-Z score of 3.52 indicates that EXO is not in any danger for bankruptcy at the moment.
  • EXO's Altman-Z score of 3.52 is fine compared to the rest of the industry. EXO outperforms 75.86% of its industry peers.
  • EXO has a debt to FCF ratio of 1.25. This is a very positive value and a sign of high solvency as it would only need 1.25 years to pay back of all of its debts.
  • EXO's Debt to FCF ratio of 1.25 is amongst the best of the industry. EXO outperforms 82.76% of its industry peers.
  • EXO has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
  • EXO has a Debt to Equity ratio of 0.08. This is in the better half of the industry: EXO outperforms 77.59% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 1.25
Altman-Z 3.52
ROIC/WACCN/A
WACC4.33%
EXO.AS Yearly LT Debt VS Equity VS FCFEXO.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

2.3 Liquidity

  • EXO has a Current Ratio of 2.21. This indicates that EXO is financially healthy and has no problem in meeting its short term obligations.
  • EXO has a Current ratio of 2.21. This is in the better half of the industry: EXO outperforms 77.59% of its industry peers.
  • A Quick Ratio of 2.21 indicates that EXO has no problem at all paying its short term obligations.
  • With a decent Quick ratio value of 2.21, EXO is doing good in the industry, outperforming 79.31% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.21
Quick Ratio 2.21
EXO.AS Yearly Current Assets VS Current LiabilitesEXO.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. EXO.AS Growth Analysis

3.1 Past

  • EXO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -104.11%.
  • The Earnings Per Share has been growing by 38.47% on average over the past years. This is a very strong growth
  • Looking at the last year, EXO shows a very negative growth in Revenue. The Revenue has decreased by -100.78% in the last year.
  • EXO shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -36.03% yearly.
EPS 1Y (TTM)-104.11%
EPS 3Y104.89%
EPS 5Y38.47%
EPS Q2Q%-104.49%
Revenue 1Y (TTM)-100.78%
Revenue growth 3Y-22.92%
Revenue growth 5Y-36.03%
Sales Q2Q%-103.68%

3.2 Future

  • Based on estimates for the next years, EXO will show a very negative growth in Earnings Per Share. The EPS will decrease by -55.57% on average per year.
  • The Revenue is expected to decrease by -93.05% on average over the next years. This is quite bad
EPS Next Y-113.47%
EPS Next 2Y-75.05%
EPS Next 3Y-55.57%
EPS Next 5YN/A
Revenue Next Year-99.97%
Revenue Next 2Y-98.17%
Revenue Next 3Y-93.05%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
EXO.AS Yearly Revenue VS EstimatesEXO.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 50B 100B 150B
EXO.AS Yearly EPS VS EstimatesEXO.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 10 20 30

More info and screens

Find the best growth stocksShow best growing peers

2

4. EXO.AS Valuation Analysis

4.1 Price/Earnings Ratio

  • EXO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • EXO is valuated quite expensively with a Price/Forward Earnings ratio of 29.96.
  • Based on the Price/Forward Earnings ratio, EXO is valued a bit more expensive than 65.52% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.19, EXO is valued a bit more expensive.
Industry RankSector Rank
PE N/A
Fwd PE 29.96
EXO.AS Price Earnings VS Forward Price EarningsEXO.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20

4.2 Price Multiples

  • EXO's Price/Free Cash Flow ratio is rather cheap when compared to the industry. EXO is cheaper than 87.93% of the companies in the same industry.
Industry RankSector Rank
P/FCF 4.71
EV/EBITDA N/A
EXO.AS Per share dataEXO.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150

4.3 Compensation for Growth

  • EXO's earnings are expected to decrease with -55.57% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-75.05%
EPS Next 3Y-55.57%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

1

5. EXO.AS Dividend Analysis

5.1 Amount

  • With a yearly dividend of 0.76%, EXO is not a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 2.44, EXO has a dividend in line with its industry peers.
  • With a Dividend Yield of 0.76, EXO pays less dividend than the S&P500 average, which is at 1.90.
Industry RankSector Rank
Dividend Yield 0.76%

5.2 History

  • The dividend of EXO decreases each year by -17.34%.
Dividend Growth(5Y)-17.34%
Div Incr Years2
Div Non Decr Years2
EXO.AS Yearly Dividends per shareEXO.AS Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 0.1 0.2 0.3 0.4

5.3 Sustainability

  • The earnings of EXO are negative and hence is the payout ratio. EXO will probably not be able to sustain this dividend level.
  • EXO's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP-14.35%
EPS Next 2Y-75.05%
EPS Next 3Y-55.57%
EXO.AS Yearly Income VS Free CF VS DividendEXO.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B

More info and screens

Find the best dividend stocksShow peers with best dividend

EXO.AS Fundamentals: All Metrics, Ratios and Statistics

EXOR NV

AMS:EXO (3/27/2026, 7:00:00 PM)

63.75

-1.05 (-1.62%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)03-23
Earnings (Next)N/A
Inst Owners28.16%
Inst Owner ChangeN/A
Ins Owners0.19%
Ins Owner ChangeN/A
Market Cap13.25B
Revenue(TTM)-302.00M
Net Income(TTM)-648.00M
Analysts86.15
Price Target116.28 (82.4%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.76%
Yearly Dividend0.45
Dividend Growth(5Y)-17.34%
DP-14.35%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.98%
PT rev (3m)-1.94%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)40.61%
EPS NY rev (3m)40.61%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-99.97%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 29.96
P/S N/A
P/FCF 4.71
P/OCF 4.71
P/B 0.36
P/tB 0.36
EV/EBITDA N/A
EPS(TTM)-3.12
EYN/A
EPS(NY)2.13
Fwd EY3.34%
FCF(TTM)13.53
FCFY21.23%
OCF(TTM)13.53
OCFY21.23%
SpS-1.45
BVpS174.97
TBVpS174.97
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.62%
ROE -1.78%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM -5096.69%
FCFM -931.13%
ROA(3y)14.68%
ROA(5y)9.18%
ROE(3y)25.64%
ROE(5y)17.39%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)18.23%
ROCE(5y)12.24%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y119.43%
OM growth 5Y70.93%
PM growth 3Y165.23%
PM growth 5Y113.99%
GM growth 3Y61.62%
GM growth 5Y43.9%
F-Score5
Asset Turnover-0.01
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 1.25
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.21
Quick Ratio 2.21
Altman-Z 3.52
F-Score5
WACC4.33%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)46.89%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-104.11%
EPS 3Y104.89%
EPS 5Y38.47%
EPS Q2Q%-104.49%
EPS Next Y-113.47%
EPS Next 2Y-75.05%
EPS Next 3Y-55.57%
EPS Next 5YN/A
Revenue 1Y (TTM)-100.78%
Revenue growth 3Y-22.92%
Revenue growth 5Y-36.03%
Sales Q2Q%-103.68%
Revenue Next Year-99.97%
Revenue Next 2Y-98.17%
Revenue Next 3Y-93.05%
Revenue Next 5YN/A
EBIT growth 1Y-102.73%
EBIT growth 3Y69.13%
EBIT growth 5Y9.34%
EBIT Next Year-105.3%
EBIT Next 3Y-27.17%
EBIT Next 5YN/A
FCF growth 1Y-14.71%
FCF growth 3Y-69.35%
FCF growth 5Y-53.45%
OCF growth 1Y-52.81%
OCF growth 3Y-76.44%
OCF growth 5Y-67.23%

EXOR NV / EXO.AS Fundamental Analysis FAQ

What is the ChartMill fundamental rating of EXOR NV (EXO.AS) stock?

ChartMill assigns a fundamental rating of 4 / 10 to EXO.AS.


What is the valuation status of EXOR NV (EXO.AS) stock?

ChartMill assigns a valuation rating of 2 / 10 to EXOR NV (EXO.AS). This can be considered as Overvalued.


What is the profitability of EXO stock?

EXOR NV (EXO.AS) has a profitability rating of 3 / 10.


Can you provide the financial health for EXO stock?

The financial health rating of EXOR NV (EXO.AS) is 8 / 10.